A Novel Method for Measuring Serum Unbound Bilirubin Levels Using Glucose Oxidase-Peroxidase and Bilirubin-Inducible Fluorescent Protein (UnaG): No Influence of Direct Bilirubin
- PMID: 32947818
- PMCID: PMC7555467
- DOI: 10.3390/ijms21186778
A Novel Method for Measuring Serum Unbound Bilirubin Levels Using Glucose Oxidase-Peroxidase and Bilirubin-Inducible Fluorescent Protein (UnaG): No Influence of Direct Bilirubin
Abstract
The glucose oxidase-peroxidase (GOD-POD) method used to measure serum unbound bilirubin (UB) suffers from direct bilirubin (DB) interference. Using a bilirubin-inducible fluorescent protein from eel muscle (UnaG), a novel GOD-POD-UnaG method for measuring UB was developed. Newborn sera with an indirect bilirubin/albumin (iDB/A) molar ratio of <0.5 were classified into four groups of DB/total serum bilirubin (TB) ratios (<5%, 5-10%, 10-20%, and ≥20%), and the correlation between the UB levels and iDB/A ratio was examined. Linear regression analysis was performed to compare UB values from both methods with the iDB/A ratio from 38 sera samples with DB/TB ratio <5% and 11 samples with DB/TB ratio ≥5%. The correlation coefficient (r) between UB values and the iDB/A ratio for the GOD-POD method was 0.8096 (DB/TB ratio <5%, n = 239), 0.7265 (5-10%, n = 29), 0.7165 (10-20%, n = 17), and 0.4816 (≥20%, n = 16). UB values using the GOD-POD-UnaG method highly correlated with the iDB/A ratio in both <5% and ≥5% DB/TB ratio sera (r = 0.887 and 0.806, respectively), whereas a low correlation (r = 0.428) occurred for ≥5% DB/TB ratio sera using the GOD-POD method. Our GOD-POD-UnaG method can measure UB levels regardless of the presence of DB.
Keywords: albumin; analyzer; bilirubin encephalopathy; glucose oxidase-peroxidase method; indirect bilirubin; neonatal intensive care unit.
Conflict of interest statement
The authors declare no conflict of interest. I.M. has received study grants and lecture and manuscript fees from Atom Medical Corp. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures






Similar articles
-
Acetaminophen elevates unbound bilirubin levels by the glucose oxidase-peroxidase method.Pediatr Int. 2021 Sep;63(9):1069-1074. doi: 10.1111/ped.14608. Epub 2021 Jul 30. Pediatr Int. 2021. PMID: 33464662
-
Bilirubin/albumin (B/A) ratios correlate with unbound bilirubin levels in preterm infants.Pediatr Res. 2021 May;89(6):1427-1431. doi: 10.1038/s41390-020-01351-z. Epub 2021 Jan 19. Pediatr Res. 2021. PMID: 33469181
-
Time-Fixed Glucose Oxidase-Peroxidase Method for Measurement of Serum Unbound Bilirubin Levels.Clin Lab. 2022 Feb 1;68(2). doi: 10.7754/Clin.Lab.2021.210617. Clin Lab. 2022. PMID: 35142193
-
Bilirubin-albumin binding, bilirubin/albumin ratios, and free bilirubin levels: where do we stand?Semin Perinatol. 2014 Nov;38(7):412-21. doi: 10.1053/j.semperi.2014.08.004. Epub 2014 Oct 7. Semin Perinatol. 2014. PMID: 25304058 Review.
-
Bilirubin Binding Capacity in the Preterm Neonate.Clin Perinatol. 2016 Jun;43(2):241-57. doi: 10.1016/j.clp.2016.01.003. Epub 2016 Feb 28. Clin Perinatol. 2016. PMID: 27235205 Free PMC article. Review.
Cited by
-
The HELP-UnaG Fusion Protein as a Bilirubin Biosensor: From Theory to Mature Technological Development.Molecules. 2025 Jan 21;30(3):439. doi: 10.3390/molecules30030439. Molecules. 2025. PMID: 39942546 Free PMC article. Review.
-
175 Years of Bilirubin Testing: Ready for Point-of-Care?Adv Healthc Mater. 2023 Jul;12(18):e2203380. doi: 10.1002/adhm.202203380. Epub 2023 Apr 10. Adv Healthc Mater. 2023. PMID: 37035945 Free PMC article.
-
Noninvasive direct bilirubin detection by spectral analysis of color images using a Mini-LED light source.Discov Nano. 2023 Feb 16;18(1):16. doi: 10.1186/s11671-023-03794-9. Discov Nano. 2023. PMID: 36795165 Free PMC article.
-
Blood ACE Phenotyping for Personalized Medicine: Revelation of Patients with Conformationally Altered ACE.Biomedicines. 2023 Feb 13;11(2):534. doi: 10.3390/biomedicines11020534. Biomedicines. 2023. PMID: 36831070 Free PMC article.
References
-
- Kitai Y., Hirai S., Okuyama N., Hirotsune M., Nishimoto S., Mizutani S., Okumura A., Kumada S., Arai H. A questionnaire survey on the efficacy of various treatments for dyskinetic cerebral palsy due to preterm bilirubin encephalopathy. Brain Dev. 2020;42:322–328. doi: 10.1016/j.braindev.2020.01.006. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous